Oral medicinal cannabinoids to relieve symptom burden in the palliative care of patients with advanced cancer: a double-blind, placebo-controlled, randomised clinical trial of efficacy and safety of 1:1 delta-9-tetrahydrocannabinol (THC) and cannabidiol (CBD)

BACKGROUND: Despite improvements in medical care, patients with advanced cancer still experience substantial symptom distress. There is increasing interest in the use of medicinal cannabinoids but little high-quality evidence to guide clinicians. This study aims to define the role of a 1:1 delta-9-t...

Descripción completa

Detalles Bibliográficos
Autores principales: Hardy, Janet, Haywood, Alison, Gogna, Gauri, Martin, Jennifer, Yates, Patsy, Greer, Ristan, Good, Phillip
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2020
Materias:
Study Protocol
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7336664/
https://www.ncbi.nlm.nih.gov/pubmed/32631447
http://dx.doi.org/10.1186/s13063-020-04541-6

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7336664/
https://www.ncbi.nlm.nih.gov/pubmed/32631447
http://dx.doi.org/10.1186/s13063-020-04541-6

Ejemplares similares